Lenis Group

Lenis is a specialized pharmaceutical company based in Ljubljana, Slovenia, dedicated to the marketing and distribution of niche medicines, orphan drugs, and unlicensed medicinal products. The company serves as a strategic partner for international pharmaceutical manufacturers, providing comprehensive market access, regulatory affairs, and pharmacovigilance services across South Eastern Europe. Lenis focuses on high-need therapeutic areas including oncology, hematology, neurology, and rare diseases, often managing named patient supply programs for critical treatments. In 2022, Lenis was acquired by Medis, a leading commercialization company in the Central and Eastern Europe region, to bolster its specialty medicine capabilities. The company is recognized for its expertise in navigating complex regulatory environments to deliver essential therapies to patients with unmet medical needs.